Puma Biotechnology, Inc., a Delaware corporation founded on April 27, 2007, is a biopharmaceutical company dedicated to developing and commercializing innovative products aimed at enhancing cancer care and improving patient outcomes. Currently, the company is marketing NERLYNX, an oral formulation of neratinib, for the treatment of HER2-positive breast cancer. For more information, visit their website at http://www.pumabiotechnology.com. Company Address: 10880 Wilshire Boulevard Suite 2150 Los Angeles, CA 90024

Complete your account application and verification in just 1 minute. The process is fully self-service and available on both RockFlow App and Web.

Once your account has been verified, you can deposit funds into your account using your preferred payment method.

Search for PBYI via RockFlow App or Web, enter the amount you want to invest, and tap Confirm to execute the trade.